Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1995-06-07
1998-12-22
Degen, Nancy
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 8, 514 21, 530395, A61K 3817, A61K 3816, C07K 1447, C07K 14705
Patent
active
058519939
ABSTRACT:
Methods of reducing tumor growth, including the suppression of tumor growth in a patient, are provided by the administration of efficacious levels of syndecan ectodomain to the extracellular environment of the tumor cell. Pharmaceutically acceptable compositions of syndecan are also provided.
REFERENCES:
Mali, M. et al., "Suppression of Tumor Cell Growth of Syndecan-1 Ectodomain," The Journal of Biological Chemistry 269:27795-27798, Nov. 1994.
Bernfield, M. et al., "Biology of the Syndecans: A Family of Transmembrane Heparan Sulfate Proteoglycans," Ann. Rev. Cell Biol. 8:365-393 (1992).
Breakefield, X.A., and DeLuca, N.A., "Herpes Simplex Virus for Gene Delivery to Neurons," New Biol. 3(3):203-218 (1991).
Elenius, K. et al., "Binding of Human Syndecan to Extracellular Matrix Proteins," J. Biol. Chem. 265(29):17837-17843 (1990).
Elenius, K., et al., "Growth Factors Induce 3T3 Cells to Express bFGF-Binding Syndecan," J. Biol. Chem. 267:6435-6441 (1992).
Elenius, K., et al., "Induced Expression of Syndecan in Healing Wounds," J. Cell Biol. 114(3):585-595 (1991).
Huang, Q., et al., "Introduction of a Foreign Gene (Escherichia coli lacZ) into Rat Neostriatal Neurons Using Herpes Simplex Virus Mutants: A Light and Electron Microscopic Study," Exp. Neurol. 115:303-316 (1992).
Inki, P., et al., "Immunohistochemical Localization of Syndecan in Mouse Skin Tumors Induced by UV Irradiation," Am. J. Pathol. 139(6):1333-1340 (1991).
Inki, P., et al., "Syndecan in Carcinomas Produced from Transformed Epithelial Cells in Nude Mice," Lab. Investig. 66(3):314-323 (1992).
Jalkanen, M., et al., "Heparan Sulfate Proteoglycans from Mouse Mammary Epithelial Cells: Localization on the Cell Surface with a Monoclonal Antibody," J. Cell Biol. 101:976-984 (1985).
Jalkanen, M., "Biology of Cell Surface Heparan Sulfate Proteoglycans," Med. Biol. 65:41-47 (1987).
Jalkanen, M., et al., "Cell Surface Proteoglycan of Mouse Mammary Epithelial Cells Is Shed by Cleavage of Its Matrix-Binding Ectodomain from Its Membrane-Associated Domain," J. Cell Biol. 105:3087-3096 (1987).
Jalkanen, M., et al., "Loss of Syndecan (cell surface proteoglycan) Expression in Mouse Mammary Epithelial Cells After Transformation with a Point-Mutated cHa-ras Proto-Oncogene," J. Cell. Biochem. Suppl. 0 (13 Part B):52, Abstract No. D 317 (1989).
Jalkanen, M., et al., "Simultaneous Loss of Syndecan Expression and Epithelial Phenotype in S115 Carcinoma Cells Exposed to Steroids," J. Cell. Biochem. Suppl. 0 (14 Part A):153, Abstract No. A 113 (1990).
Jalkanen, M., et al., "Binding of Extracellular Effector Molecules by Cell Surface Proteoglycans," in: Receptors for Extracellular Matrix, J.A. MacDonald and R.P. Mecham (Eds.), San Diego: Academic Press, pp. 1-37 (1991).
Jalkanen, M., et al., "Stimulation of Syndecan Gene Expression in Mesenchymal Cells by bFGF and TGF.beta.," J. Biochem. Suppl. (15F):223, Abstract No. CF 115 (1991).
Jalkanen, M., et al., "Syndecan, a Regulator of Cell Behaviour, is Lost in Malignant Transformation," Biochem. Soc. Trans. 19(4):1069-1072 (1991).
Kiefer, M.C., et al., "Ligand-Affinity Cloning and Structure of a Cell Surface Heparan Sulfate Proteoglycan that Binds Basic Fibroblast Growth Factor," Proc. Natl. Acad. Sci. USA 87:6985-6989 (1990).
King, R.J.B., et al., "The Role of Receptors in the Steroidal Regulation of Tumour Cell Proliferation," J. Steroid Biochem. 7:869-873 (1976).
Koda, J.E., et al., "Heparan Sulfate Proteoglycans from Mouse Mammary Epithelial Cells," J. Biol. Chem. 260(13):8157-8162 (1985).
Leppa, S., et al., "Syndecan Expression Regulates Cell Morphology and Growth of Mouse Mammary Epithelial Tumor Cells," Proc. Natl. Acad. Sci. USA 89:932-936 (1992).
Leppa, S., et al., "Steroid-Induced Epithelial-Fibroblastic Conversion Associated with Syndecan Suppression in S115 Mouse Mammary Tumor Cells," Cell Reg. 2:1-11 (1991).
Mali, M. et al., "Sequence of Human Syndecan Indicates a Novel Gene Family of Integral Membrane Proteoglycans," J. Biol. Chem. 265(12):6884-6889 (1990).
Mali, M., et al., "Inhibition of Basic Fibroblast Growth Factor-Induced Growth Promotion by Overexpression of Syndecan-1," J. Biol. Chem. 268(32):24215-24222 (Nov. 15, 1993).
Miettinen, H.M., and Jalkanen, M., "The Cytoplasmic Domain of Syndecan-1 is Not Required for Association with Triton X-100-Insoluble Material," J. Cell Sci. 107(6):1571-1581 (Jun., 1994).
Phillips, R.M., et al., "A Critical Appraisal of the Predictive Value of In Vitro Chemosensitivity Assays," J. Nat. Canc. Inst. 82(18):1457-1468 (1990).
Quintanilla, M., et al., "Carcinogen-Specific Mutation and Amplification of Ha-ras During Mouse Skin Carcinogenesis," Nature 322:78-80 (1986).
Rapraeger, A., and Bernfield, M., "Cell Surface Proteoglycan of Mammary Epithelial Cells," J. Biol. Chem. 260(7):4103-4109 (1985).
Rapraeger, A., et al., "The Cell Surface Proteoglycan from Mouse Mammary Epithelial Cells Bears Chondroitin Sulfate and Heparan Sulfate Glycosaminoglycans," J. Biol. Chem. 260(20):11046-11052 (1985).
Rapraeger, A., et al., "Cell Surface Proteoglycan Associates with the Cytoskeleton at the Basolateral Cell Surface of Mouse Mammary Epithelial Cells," J. Cell Biol. 103:2683-2696 (1986).
Salmivirta, M., et al., "Syndecan from Embryonic Tooth Mesenchyme Binds Tenascin," J. Biol. Chem. 266(12):7733-7739 (1991).
Salmivirta, M., et al., "Neurite Growth-Promoting Protein (Amphoterin, p30) Binds Syndecan," Exp. Cell Res. 200:444-451 (1992).
Sanderson, R.D., and Bernfield, M., "Molecular Polymorphism of a Cell Surface Proteoglycan: Distinct Structures on Simple and Stratified Epithelia," Proc. Natl. Acad. Sci. USA 85:9562-9566 (1988).
Sanderson, R.D., et al., "B Lymphocytes Express and Lose Syndecan at Specific Stages of Differentiation," Cell Reg. 1:27-35 (1989).
Saunders, S., and Bernfield, M., "Cell Surface Proteoglycan Binds mouse Mammary Epithelial Cells to Fibronectin and Behaves as a Receptor for Interstitial Matrix," J. Cell Biol. 106:423-430 (1988).
Saunders, S., et al., "Mammary Epithelial Cells Transfected with Antisense cDNA Reduce Cell Surface Syndecan and Become Fibroblastic in Morphology," J. Cell Biol. 109:5a, Abstract No. 7 (1989).
Saunders, S., et al., "Molecular Cloning of Syndecan, an Integral Membrane Proteoglycan," J. Cell Biol. 108:1547-1556 (1989).
Thesleff, I., et al., "Cell Surface Proteoglycan Expression Correlates with Epithelial-Mesenchymal Interaction During Tooth Morphogenesis," Devel. Biol. 129:565-572 (1988).
Vaahtokari, A., et al., "Associations Between Transforming Growth Factor .beta.1 RNA Expression and Epithelial-Mesenchymal Interactions During Tooth Morphogenesis," Develoopment 113:985-994 (1991).
Vainio, S., et al., "Epithelial-Mesenchymal Interactions Regulate the Stage-Specific Expression of a Cell Surface Proteoglycan, Syndecan, in the Developing Kidney," Devel. Biol. 134:382-391 (1989).
Vainio, S., et al., "Syndecan and Tenascin Expression Is Induced by Epithelial-Mesenchymal Interactions in Embryonic Tooth Mesenchyme," J. Cell Biol. 108:1945-1954 (1989).
Vainio, S., et al., "Expression of Syndecan Gene Is Induced Early, Is Transient, and Correlates with Changes in Mesenchymal Cell Proliferation During Tooth Organogenesis," Devel. Biol. 147:322-333 (1991).
Wilkinson, D.G., et al., "Expression Pattern of the FGF-Related Proto-Oncogene int-2 Suggests Multiple Roles in Fetal Development," Development 105:131-136 (1989).
Yayon, A., et al., "Cell Surface, Heparin-Like Molecules are Required for Binding of Basic Fibroblast Growth Factor to its High Affinity Receptor,"Cell 64:841-848 (1991).
Phillips et al. "A Critical Appraisal of The Predictive Value of In Vitro Chemosensitivity Assays" J. Natl. Cancer Inst. 82(18)1457-1468 1990.
Jalkanen Markku
Mali Marku
BioTie Therapies Ltd.
Degen Nancy
LandOfFree
Suppression of tumor cell growth by syndecan-1 ectodomain does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Suppression of tumor cell growth by syndecan-1 ectodomain, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Suppression of tumor cell growth by syndecan-1 ectodomain will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2047761